Search results
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And...
Benzinga· 5 days agoA co-exclusive license to co-commercialize Novavax’s current stand-alone adjuvanted COVID-19 vaccine...
COVID patient testing, isolation of sick staff cut in-hospital viral spread, modeling study suggests
Center for Infectious Disease Research and Policy· 16 hours agoThe study period spanned the predominance of different viral variants and the availability of...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 5 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID ...
Feldman: COVID isn't done with us yet
The Courier & Press via Yahoo News· 2 hours agoA new booster formulation recommended for most people is anticipated for the fall. Vaccination greatly reduces the risk of severe disease and long COVID. The politicalization ...
...Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
WRBL Columbus· 5 days ago-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY). The terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current ...
AstraZeneca withdraws its COVID-19 vaccine from global market
The Hill via AOL· 7 days agoAstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 6 days agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
COVID-19 deaths increase to 4 in N.B., hospitalizations drop to 3, fewer than flu admissions
CBC via Yahoo News· 19 hours agoCOVID-19 deaths in New Brunswick doubled to four, week-over-week, while hospitalizations for or with...
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 4 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Clinical Trials Arena via Yahoo Finance· 3 hours agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...
